90 related articles for article (PubMed ID: 8859779)
1. Transgenic mice carrying the human KRAS oncogene under the control of a thyroglobulin promoter: KRAS expression in thyroids analyzed by in situ hybridization.
Chiappetta G; Fabien N; Picone A; Califano D; Monaco C; de Franciscis V; Vecchio G; Santelli G
Oncol Res; 1996; 8(2):85-93. PubMed ID: 8859779
[TBL] [Abstract][Full Text] [Related]
2. Production of transgenic mice expressing the Ki-ras oncogene under the control of a thyroglobulin promoter.
Santelli G; de Franciscis V; Portella G; Chiappetta G; D'Alessio A; Califano D; Rosati R; Mineo A; Monaco C; Manzo G
Cancer Res; 1993 Nov; 53(22):5523-7. PubMed ID: 8221693
[TBL] [Abstract][Full Text] [Related]
3. Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter.
Rochefort P; Caillou B; Michiels FM; Ledent C; Talbot M; Schlumberger M; Lavelle F; Monier R; Feunteun J
Oncogene; 1996 Jan; 12(1):111-8. PubMed ID: 8552381
[TBL] [Abstract][Full Text] [Related]
4. Differentiated carcinomas develop as a consequence of the thyroid specific expression of a thyroglobulin-human papillomavirus type 16 E7 transgene.
Ledent C; Marcotte A; Dumont JE; Vassart G; Parmentier M
Oncogene; 1995 May; 10(9):1789-97. PubMed ID: 7753555
[TBL] [Abstract][Full Text] [Related]
5. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
[TBL] [Abstract][Full Text] [Related]
6. Human N-ras, TRK-T1, and RET/PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells.
Portella G; Vitagliano D; Borselli C; Melillo RM; Salvatore D; Rothstein JL; Vecchio G; Fusco A; Santoro M
Oncol Res; 1999; 11(9):421-7. PubMed ID: 10821536
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
[TBL] [Abstract][Full Text] [Related]
8. Cloning and molecular dissection of the 8.8 kb pig uroplakin II promoter using transgenic mice and RT4 cells.
Kwon DN; Choi YJ; Park JY; Cho SK; Kim MO; Lee HT; Kim JH
J Cell Biochem; 2006 Oct; 99(2):462-77. PubMed ID: 16619260
[TBL] [Abstract][Full Text] [Related]
9. Expression of v-Ha-ras driven by the calcitonin/calcitonin gene-related peptide promoter: a novel transgenic murine model for medullary thyroid carcinoma.
Johnston D; Hatzis D; Sunday ME
Oncogene; 1998 Jan; 16(2):167-77. PubMed ID: 9464534
[TBL] [Abstract][Full Text] [Related]
10. APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression.
Janssen KP; Alberici P; Fsihi H; Gaspar C; Breukel C; Franken P; Rosty C; Abal M; El Marjou F; Smits R; Louvard D; Fodde R; Robine S
Gastroenterology; 2006 Oct; 131(4):1096-109. PubMed ID: 17030180
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice carrying a PSArasT24 hybrid gene develop salivary gland and gastrointestinal tract neoplasms.
Schaffner DL; Barrios R; Shaker MR; Rajagopalan S; Huang SL; Tindall DJ; Young CY; Overbeek PA; Lebovitz RM; Lieberman MW
Lab Invest; 1995 Mar; 72(3):283-90. PubMed ID: 7534850
[TBL] [Abstract][Full Text] [Related]
12. Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene.
Coppée F; Gérard AC; Denef JF; Ledent C; Vassart G; Dumont JE; Parmentier M
Oncogene; 1996 Oct; 13(7):1471-82. PubMed ID: 8875985
[TBL] [Abstract][Full Text] [Related]
13. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
[TBL] [Abstract][Full Text] [Related]
14. [Transgenic models of human thyroid pathologies: hyperfunctional adenoma, anaplastic cancer, differentiated cancer, hypothyroidism].
Ledent C
Bull Mem Acad R Med Belg; 1996; 151(2):195-201. PubMed ID: 9004925
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of c-ras reactivates thyroglobulin synthesis in middle-T transformed thyroid cells.
Di Jeso B; Feliciello A; Pacifico F; Iannelli A; D'Armiento F; Liguoro D; Giuliano P; Ferulano G; Avvedimento EV
Cell Growth Differ; 1995 Oct; 6(10):1315-9. PubMed ID: 8845309
[TBL] [Abstract][Full Text] [Related]
16. Real time RT-PCR analysis of thyroglobulin mRNA in peripheral blood in patients with congenital athyreosis and with differentiated thyroid carcinoma after stimulation with recombinant human thyrotropin.
Kaufmann S; Schmutzler C; Schomburg L; Körber C; Luster M; Rendl J; Reiners C; Köhrle J
Endocr Regul; 2004 Jun; 38(2):41-9. PubMed ID: 15497927
[TBL] [Abstract][Full Text] [Related]
17. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.
Vitagliano D; Portella G; Troncone G; Francione A; Rossi C; Bruno A; Giorgini A; Coluzzi S; Nappi TC; Rothstein JL; Pasquinelli R; Chiappetta G; Terracciano D; Macchia V; Melillo RM; Fusco A; Santoro M
Oncogene; 2006 Aug; 25(39):5467-74. PubMed ID: 16785999
[TBL] [Abstract][Full Text] [Related]
18. Amplification of Ki-ras and elevation of MAP kinase activity during mammary tumor progression in C3(1)/SV40 Tag transgenic mice.
Liu ML; Von Lintig FC; Liyanage M; Shibata MA; Jorcyk CL; Ried T; Boss GR; Green JE
Oncogene; 1998 Nov; 17(18):2403-11. PubMed ID: 9811472
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
[TBL] [Abstract][Full Text] [Related]
20. Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice.
Grippo PJ; Nowlin PS; Demeure MJ; Longnecker DS; Sandgren EP
Cancer Res; 2003 May; 63(9):2016-9. PubMed ID: 12727811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
